tiprankstipranks
Eloxx Pharmaceuticals (ELOXD)
OTHER OTC:ELOXD
US Market

Eloxx Pharmaceuticals (ELOXD) Financial Statements

286 Followers

Eloxx Pharmaceuticals Financial Overview

Eloxx Pharmaceuticals's market cap is currently $377.44K. The company's EPS TTM is $; its P/E ratio is -8.02; Eloxx Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 23Mar 22Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -695.00K$ -960.00K$ -571.00K$ -559.00K
Operating Income$ -6.44M$ -34.42M$ -42.35M$ -29.44M$ -50.55M
EBITDA$ -6.44M$ -33.72M$ -41.39M$ -28.87M$ -50.00M
Net Income$ -6.00M$ -36.06M$ -66.73M$ -34.58M$ -50.87M
Balance Sheet
Cash & Short-Term Investments$ 4.79M$ 19.47M$ 42.57M$ 24.72M$ 56.32M
Total Assets$ 5.27M$ 21.12M$ 45.14M$ 26.48M$ 58.95M
Total Debt$ 1.00M$ 13.38M$ 13.46M$ 12.04M$ 15.76M
Net Debt$ -3.79M$ -6.08M$ -29.11M$ -12.69M$ -6.77M
Total Liabilities$ 17.18M$ 31.78M$ 22.75M$ 16.25M$ 22.73M
Stockholders' Equity$ -11.91M$ -10.66M$ 22.38M$ 10.23M$ 36.21M
Cash Flow
Free Cash Flow$ 0.00$ -31.91M$ -35.09M$ -28.17M$ -39.43M
Operating Cash Flow$ -6.33M$ -31.84M$ -35.00M$ -28.17M$ -39.39M
Investing Cash Flow$ 1.00K$ -66.00K$ 2.06M$ 33.79M$ -33.52M
Financing Cash Flow$ 11.00M$ 8.81M$ 50.79M$ -3.44M$ 46.80M
Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History

Eloxx Pharmaceuticals Debt to Assets

Eloxx Pharmaceuticals Cash Flow

Eloxx Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.